At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Apr 29, 2026 at 20:00 ET
Three directors of Emergent BioSolutions sold a total of approximately $385K in open-market shares over two days, representing less than 0.1% of market cap. This is routine insider selling, not indicative of material concerns, especially given concurrent non-cash stock grants to the same directors.
- 3 directors sold shares: Katkin Keith ($128K), DeGolyer Donald W ($121K), Zoon Kathryn C ($135K)
- Total open-market sales: ~$385K, ~0.09% of $437M market cap
- All sales occurred at ~$8.28-$8.36 per share on April 30 and May 1, 2026
- Multiple directors also received non-cash stock grants (A) on April 30, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access